
UMC · NYSE
Expected to report Jan 27, 2027 — estimated from last year’s reporting date.
Consensus is $0.25 EPS for Dec 2026 across 1 estimates, ranging $0.25 to $0.25.
UMC delivered a stronger operating quarter, though reported ADS EPS of $0.21 fell short of the $0.23 consensus by 8.7%. Revenue increased 8% sequentially to NT$74.24 billion, gross margin expanded 150 basis points to 34%, and utilization rose to 92% from 85% in Q2. Year over year, revenue grew 25.6% and gross profit increased 43.0% to NT$25.20 billion. Net income attributable to the parent was NT$16.43 billion, up from NT$14.98 billion a year earlier; ordinary-share EPS was NT$1.32 versus NT$1.20.
The defining story was tight capacity supporting stronger near-term demand and a more constructive pricing outlook. Shipments hit a record above 1.2 million 12-inch-equivalent wafers, and management expects low-single-digit shipment growth and comparable gross margin in Q4. For 2027, it anticipates roughly 10% blended ASP growth, but rising raw-material costs and higher depreciation are likely to constrain gross-margin progress. UMC is accelerating investment in AI-related specialty technologies: the board approved about $3.2 billion in additional expansion spending, with most new capacity not ramping until late 2028. Meanwhile, nine-month earnings more than doubled, but NT$28.10 billion of equity-method income and NT$7.05 billion of fair-value gains materially lifted the result, making the year-to-date net-income comparison stronger than the operating growth alone suggests.
Higher utilization and record shipments lifted quarterly revenue and margins. Operating income increased to NT$18.64 billion from NT$11.12 billion in Q3 2025, while parent-attributable net income rose to NT$16.43 billion from NT$14.98 billion. The reported $0.21 EPS was below the $0.23 consensus; UMC reported NT$1.32 per ordinary share and $0.206 per ADS.
Management described healthy demand across market segments, with selected technologies already constrained by available capacity. Q3 shipments rose 7.3% sequentially to more than 1.2 million 12-inch-equivalent wafers, a record, and utilization reached 92% versus 85% in Q2. Several 12-inch fabs were at full capacity, while 8-inch operations also recovered. Management cautioned that utilization below 100% can reflect a mismatch between demand and fab configuration, including capacity being converted for new technologies, rather than idle facilities.
UMC said 2027 marks a change in its blended ASP trajectory, from erosion toward an expected year-on-year increase of about 10%. This is a company-wide blended figure, incorporating both like-for-like pricing and richer product and technology mix; management did not provide a like-for-like breakdown. Stronger demand, tight capacity in selected technologies and inflationary cost increases are part of customer discussions. The pricing opportunity is not expected to translate directly into higher gross margin: depreciation is expected to grow at least at a low-single-digit rate in 2027 and may rise further in 2028, while raw-material costs are also increasing. Management expects a healthy EBITDA margin structure but said those costs will pressure gross margin.
UMC is shifting investment toward customer-backed opportunities in silicon photonics, advanced packaging and related specialty technologies. Management said AI-related revenue is close to $300 million in 2026 and could exceed a quarter of total revenue in about three years. Near-term growth remains constrained by available capacity; most of the newly planned capacity is scheduled to start ramping in late 2028 and reach full scale by 2030.
The year-to-date earnings surge included substantial investment-related contributions, so it was not solely a reflection of foundry operations. Nine-month net income was NT$74.73 billion versus NT$31.54 billion in 2025, while operating income rose to NT$44.87 billion from NT$31.72 billion. Equity-method profit reached NT$28.10 billion, compared with NT$1.49 billion a year earlier, and other gains included NT$7.05 billion of fair-value gains versus NT$0.11 billion. In Q3, however, fair-value movements were a NT$1.12 billion loss, compared with a NT$1.20 billion gain a year earlier; equity-method profit was NT$1.68 billion versus NT$1.25 billion.
Cash and cash equivalents increased to NT$142.62 billion at September 30 from NT$110.66 billion at December 31, 2025. Operating cash flow was NT$85.69 billion in the first nine months, against NT$66.86 billion a year earlier. Capital expenditure on property, plant and equipment was NT$32.61 billion over the period, and UMC paid NT$32.70 billion in cash dividends and repurchased NT$3.10 billion of treasury stock. Management said it will keep investment disciplined while meeting customer demand and acknowledged that the expansion will add depreciation over the coming years.